Evaluation of multimodality treatment of locoregional esophageal carcinoma by southwest oncology Group 9060

Cancer

Volumn 78, Issue 9, 1996, Pages 1851-1856

  Poplin, Elizabeth A ^a   Jacobson, Joth ^b   Herskovic, Arnold ^c   Panella, Timothy J ^d   Valdivieso, Manuel ^c   Hutchins, Laura F ^e   Macdonald, John S ^f  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

^c OAKWOOD HOSPITAL AND MEDICAL CENTER   (United States)

^d Thompson Cancer Center   (United States)

^e UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^f TEMPLE UNIVERSITY   (United States)

Author keywords

chemoradiotherapy; combined modality; esophageal carcinoma; infusional 5 fluorouracil

Indexed keywords

FLUOROURACIL;

ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CLINICAL ARTICLE; DOSE RESPONSE; ESOPHAGUS CARCINOMA; HUMAN; INTERMETHOD COMPARISON; MORTALITY; PATIENT COMPLIANCE; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; TREATMENT PLANNING;

ADENOCARCINOMA; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CISPLATIN; COMBINED MODALITY THERAPY; ESOPHAGEAL NEOPLASMS; FEMALE; FLUOROURACIL; HUMANS; MALE; MIDDLE AGED; PILOT PROJECTS; SURVIVAL RATE;

EID: 0029851204     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19961101)78:9<1851::AID-CNCR2>3.0.CO;2-I     Document Type: Article

References (17)

1. Ellis FH. Treatment of carcinoma of the esophagus or cardia. Mayo Clin Proc 1989;64:945.
2. Katic MR, Wilkins EW, Grillo HC. Three decades of treatment of esophageal squamous carcinoma at the Massachusetts General Hospital. J Thorac Cardiovasc Surg 1990;99:929-38.
3. Orringer MB. Transhiatal esophagectomy without thoracotomy for carcinoma of the thoracic esophagus. Ann Surg 1994;200:282.
4. Earlam R, Cunha-Melo Jr. Oesophageal squamous cell carcinoma I: a critical review of radiotherapy. Br J Surg 1980; 67:457-61.
5. Coia LR, Engstrom PF, Paul AR, Stafford PM, Hanks G. Non-surgical management of esophageal cancer: report of a study of combined radiotherapy and chemotherapy. J Clin Oncol 1987;5:1783-90.
6. Herskovic A, Martz K, Al-Sarraf M, Leichman L, Brindle J, Vaitkevicius V, et al. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med 1992;326:1593-8.
7. Forastiere AA, Orringer MB, Perez-Tamayo C, Urba SG, Zohurak M. Preoperative chemoradiation followed by transhiatal esophagectomy for carcinoma of the esophagus: final report. J Clin Oncol 1993;11:1118-23.
8. Wolfe WG, Vaughn AL, Hilliard RN, Seigler F, Hathorn JW, Leopold KA, et al. Survival of patients with carcinoma of the esophagus treated with combined-modality therapy. J Thorac Cardiovasc Surg 1993;105:749-56.
9. Poplin EA, Khanuja PS, Kraut MJ, Herskovic AM, Lattin PB, Cummings G, et al. Chemoradiotherapy of esophageal carcinoma. Cancer 1994;74:1217-24.
10. SAS/STAT User's Guide. Version 6., 4th edition. Cary, NC:SAS Institute Inc, 1990.
11. Fabian C, Giri S, Estes N, Tangen C, Poplin E, Vogel S, et al. Adjuvant continuous infusion 5-FU, whole abdominal radiation and tumor bed boost in Dukes C2 colon carcinoma: a southwest Oncology Group Pilot Study. Int J Radiat Oncol Biol Phys 1995;32:457-64.
12. O'Connell MJ, Martenson JA, Wieand HS, Krook JE, MacDonald JS, Haller DG, et al. Improving adjuvant therapy for rectal cancer by combining protracted-infusion fluorouracil with radiation therapy after curative surgery. N Engl J Med 1994;331:502-7.
13. Lokich JJ, Shea M, Chaffey J. Sequential infusional 5-fluorouracil followed by concomitant radiation for tumors of the esophagus and gastroesophageal junction. Cancer 1987; 60:275-9.
14. Hordijk ML. Restaging after radiotherapy and chemotherapy: value of endoscopic ultrasonography. Endoscopic Ultrasonography, Part I. Gastrointest Endosc Clin North Am 1995;5(3):601-5.
15. Rich T, Ajani JA, et al. Chemoradiation therapy for anal canal cancer: radiation plus continuous infusion of fluorouracil with or without cisplatin. Radiother Oncol 1993;27:209-15.
16. Du XX, Doerschuk CM, Orazi A, Williams DA. A bone marrow stromal-derived growth factor, interleukin-11, stimulates recovery of small intestinal mucosal cells after cytoablative therapy. Blood 1994;83:33-7.
17. Ajani JA, Ilson D, Bhalla K, Forastiere A, Pazdur R, Martin L, et al. Taxol, Cisplatin, and 5-FU (TCF): a multi-institutional phase II study in patients with carcinoma of the esophagus. 1995;14:489.